R. Sayer

发表

Genomic signatures to guide the use of chemotherapeutics

H. Dressman, J. Marks, J. Nevins, 2006, Nature Medicine.

An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.

Anil Potti, Andrea Bild, Geoffrey S Ginsburg, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genomic signatures to guide the use of chemotherapeutics

H. Dressman, J. Marks, J. Nevins, 2006 .

Retraction: Genomic signatures to guide the use of chemotherapeutics

H. Dressman, J. Marks, J. Nevins, 2011, Nature Medicine.

Corrigenda: Genomic signatures to guide the use of chemotherapeutics

H. Dressman, J. Marks, J. Nevins, 2007, Nature Medicine.

Identification of genes associated with ovarian cancer metastasis using microarray expression analysis

H K Dressman, M. West, H. Dressman, 2006, International Journal of Gynecologic Cancer.

Prognostic gene expression signature for high-grade serous ovarian cancer

P. Fasching, A. Talhouk, J. Chang-Claude, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Successful resection of obstructing airway granulation tissue following lung transplantation using endobronchial laser (Nd:YAG) therapy.

R. Sayer, B. Madden, A. Murday, 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Growing Teratoma Syndrome in the Setting of Sarcoidosis: A Case Report and Literature Review

R. Sayer, Raghwa N. Sharma, B. Gao, 2022, Current oncology.

Extended cytoreduction of intraabdominal metastatic ovarian cancer in the left upper quadrant utilizing en bloc resection.

R. Sayer, M. Hoffman, S. Tebes, 2007, American journal of obstetrics and gynecology.

The vascular portion of the cardinal ligament: surgical significance during radical hysterectomy for cervical cancer.

R. Sayer, A. Hakam, H. Salihu, 2008, American journal of obstetrics and gynecology.

An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer (Journal of Clinical Oncology (2007) 25 (517-525))

M. West, H. Dressman, J. Nevins, 2012 .

High expression of insulin-like growth factor binding protein–2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels

C. Blanchette, A. Berchuck, J. Lancaster, 2006, International Journal of Gynecologic Cancer.

Giant Pelvic Retroperitoneal Leiomyoma Arising From the Rectal Wall

R. Sayer, C. Amundsen, 2003, Obstetrics and gynecology.

Corrigendum: Genomic signatures to guide the use of chemotherapeutics

H. Dressman, J. Nevins, P. Febbo, 2008 .

High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer.

A. Berchuck, J. Lancaster, J. Pittman, 2005, Gynecologic oncology.

Regional cooling significantly reduces liposomal doxorubicin-induced palmar-plantar erythrodysesthesias (PPE) in patients with recurrent ovarian cancer.

R. Sayer, S. Apte, S. Tedjarati, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.

R. Sayer, M. Martino, M. Hoffman, 2007, Gynecologic oncology.

Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancer.

A. Berchuck, J. Lancaster, R. Sayer, 2003, Gynecologic oncology.

High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survival.

C. Blanchette, A. Berchuck, J. Lancaster, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer.

A. Berchuck, K. Blackwell, R. Sayer, 2004, Gynecologic Oncology.

Clitoroplasty

R. Sayer, M. Hoffman, A. Deutsch, 2007 .